Mm. Morrin et al., MR cholangiopancreatography of pancreaticobiliary diseases: Comparison of single-shot RARE and multislice HASTE sequences, CLIN RADIOL, 55(11), 2000, pp. 866-873
AIMS: We prospectively compared two breath-hold magnetic resonance cholangi
opancreatography (MRCP) sequences: single-shot rapid acquisition with relax
ation enhancement (RARE) and multislice half-Fourier acquisition single-sho
t turbo spin echo (HASTE) in imaging the pancreaticobiliary system.
PATIENTS AND METHODS: The diagnostic accuracy of single-shot RARE and multi
slice WASTE was studied in 34 subjects who had undergone conventional chola
ngiopancreatography. Overall image quality, duct conspicuity, image artifac
t, signal intensity and contrast-to-noise ratios were assessed independentl
y by two radiologists who were unaware of the underlying diagnosis.
RESULTS: Both sequences had comparable diagnostic accuracy regarding a norm
al biliary system, choledocholithiasis, extra-hepatic and intra-hepatic str
ictures, Single-shot RARE was superior to multislice HASTE in diagnosing a
normal pancreatic system, pancreatic and intrahepatic duct strictures, whil
e providing significantly better image quality (mean +/- SE 3.7 +/- 0.07 vs
3.3 +/- 0.08: P = 0.02) and significantly less image artifact (mean +/- SE
3.6 +/- 0.07 vs 3.2 +/- 0.08: P = 0.01), Single-shot RARE provided signifi
cantly better duct conspicuity regarding the pancreatic duct within the bod
y (2.7 +/- 0.2 vs 2.1 +/- 0.2: P = 0.003) and tail (2.4 +/- 0.2 vs 1.6 +/-
0.2; P = 0.0001), as well as the intrahepatic ducts (3.0 +/- 0.1 vs 2.6 +/-
0.1: P = 0.004) but there was no significant difference regarding the rema
inder of the biliary tree.
CONCLUSION: Single-shot RARE provides superior image quality, duct conspicu
ity with the added advantage of less image artifact and shorter acquisition
time, However, volume averaging can cause common bile duct stones to be mi
ssed. Therefore, multislice HASTE sequences should still be acquired if cho
ledocholithiasis is suspected. Larger studies are required to assess the di
agnostic efficacy of single-shot RARE sequences in pancreatic duct and intr
a-hepatic duct disease. (C) 2000 The Royal College of Radiologists.